<DOC>
	<DOCNO>NCT01919151</DOCNO>
	<brief_summary>Prognostic predictive value assess patient micrometastasis status blood bone marrow diagnose GI cancer . 2 different patient subgroup currently study , patient cancer pancreas patient liver metastasis secondary colorectal cancer . Our hypothesis patient detective circulate tumor cell blood disseminate tumour cell bone marrow diagnosis advance disease negative patient . This information may therapeutic interest .</brief_summary>
	<brief_title>Micrometastasis Gastrointestinal Cancer</brief_title>
	<detailed_description>Oncological overall outcome include patient consecutively registrated out-patient clinic . At end follow-up survival data analyse accord presence tumor cell blood bone marrow , prognostic impact presence assess .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>1 . Histological proven adenocarcinoma pancreas 2 . Histological/radiological verify colorectal liver metastases 3 . Consent capable patient 4 . Signed write , inform consent 1 . Patient'history malignancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>survival</keyword>
</DOC>